Cargando…

Targeting in Cancer Therapies

Detalles Bibliográficos
Autores principales:	Mangues, Ramon, Vázquez, Esther, Villaverde, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635766/ https://www.ncbi.nlm.nih.gov/pubmed/29083369 http://dx.doi.org/10.3390/medsci4010006

Ejemplares similares

Efficient bioactive oligonucleotide‐protein conjugation for cell‐targeted cancer therapy
por: Aviñó, Anna, et al.
Publicado: (2019)

Selective depletion of metastatic stem cells as therapy for human colorectal cancer
por: Céspedes, María Virtudes, et al.
Publicado: (2018)

Subcutaneous preconditioning increases invasion and metastatic dissemination in mouse colorectal cancer models
por: Alamo, Patricia, et al.
Publicado: (2014)

Recombinant pharmaceuticals from microbial cells: a 2015 update
por: Sanchez-Garcia, Laura, et al.
Publicado: (2016)

Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models
por: Medina-Gutiérrez, Esperanza, et al.
Publicado: (2022)

Novel Endometrial Cancer Models Using Sensitive Metastasis Tracing for CXCR4-Targeted Therapy in Advanced Disease
por: Medina-Gutiérrez, Esperanza, et al.
Publicado: (2022)

A CXCR4-targeted nanocarrier achieves highly selective tumor uptake in diffuse large B-cell lymphoma mouse models
por: Falgàs, Aïda, et al.
Publicado: (2020)

Intracellular CXCR4(+) cell targeting with T22-empowered protein-only nanoparticles
por: Unzueta, Ugutz, et al.
Publicado: (2012)

Ion-dependent slow protein release from in vivo disintegrating micro-granules
por: Álamo, Patricia, et al.
Publicado: (2021)

Time-Prolonged Release of Tumor-Targeted Protein–MMAE Nanoconjugates from Implantable Hybrid Materials
por: Serna, Naroa, et al.
Publicado: (2022)

GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases
por: Sala, Rita, et al.
Publicado: (2022)

Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4(+) Cancers
por: Cano-Garrido, Olivia, et al.
Publicado: (2021)

Specific Cytotoxic Effect of an Auristatin Nanoconjugate Towards CXCR4(+) Diffuse Large B-Cell Lymphoma Cells
por: Falgàs, Aïda, et al.
Publicado: (2021)

Probing the Biosafety of Implantable Artificial Secretory Granules for the Sustained Release of Bioactive Proteins
por: Álamo, Patricia, et al.
Publicado: (2023)

An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination
por: Pallarès, Victor, et al.
Publicado: (2020)

Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4
por: Serna, Naroa, et al.
Publicado: (2021)

CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma
por: Rioja-Blanco, Elisa, et al.
Publicado: (2022)

A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model
por: Rioja-Blanco, Elisa, et al.
Publicado: (2022)

Fluorescent Dye Labeling Changes the Biodistribution of Tumor-Targeted Nanoparticles
por: Álamo, Patricia, et al.
Publicado: (2020)

Selective delivery of T22-PE24-H6 to CXCR4(+) diffuse large B-cell lymphoma cells leads to wide therapeutic index in a disseminated mouse model
por: Falgàs, Aïda, et al.
Publicado: (2020)

Artificial Inclusion Bodies for Clinical Development
por: Sánchez, Julieta M., et al.
Publicado: (2019)

T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo
por: Núñez, Yáiza, et al.
Publicado: (2023)

Focusing in bioproduction science
por: Villaverde, Antonio
Publicado: (2005)

A new editorial board for a new editorial period
por: Villaverde, Antonio
Publicado: (2004)

Nanotechnology, bionanotechnology and microbial cell factories
por: Villaverde, Antonio
Publicado: (2010)

Old bugs for new tasks; the microbial offer in the proteomics era
por: Villaverde, Antonio
Publicado: (2002)

Engineering building blocks for self-assembling protein nanoparticles
por: Vázquez, Esther, et al.
Publicado: (2010)

Structural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli
por: Rueda, Fabián, et al.
Publicado: (2016)

Recombinant protein production in the new Millennium
por: Villaverde, Antonio, et al.
Publicado: (2007)

Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4(+) head and neck squamous cell carcinoma tumors
por: Rioja-Blanco, Elisa, et al.
Publicado: (2022)

The Diphtheria Toxin Translocation Domain Impairs Receptor Selectivity in Cancer Cell-Targeted Protein Nanoparticles
por: Voltà-Durán, Eric, et al.
Publicado: (2022)

Targeted cancer therapies
por: Yan, Li, et al.
Publicado: (2011)

Targeted therapies for cancer
por: Zhou, Zhijun, et al.
Publicado: (2022)

Bacterial cell factories for recombinant protein production; expanding the catalogue
por: Ferrer-Miralles, Neus, et al.
Publicado: (2013)

Cancer biomarkers for targeted therapy
por: Liu, Delong
Publicado: (2019)

Nanomedicine in Cancer Targeting and Therapy
por: Palamà, Ilaria Elena, et al.
Publicado: (2022)

Systems metabolic engineering, industrial biotechnology and microbial cell factories
por: Lee, Sang Yup, et al.
Publicado: (2012)

Bacterial mimetics of endocrine secretory granules as immobilized in vivo depots for functional protein drugs
por: Céspedes, María Virtudes, et al.
Publicado: (2016)

Post-production protein stability: trouble beyond the cell factory
por: Vazquez, Esther, et al.
Publicado: (2011)

Combinations of targeted therapies in human cancers
por: Decaudin, Didier, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2dbutlf9l0hcrr1i0v6qnj8n66